Murad Saftarovich Novruzbekov

Murad Saftarovich Novruzbekov

Auto-generated profile, based on publicly available information

Murad Saftarovich Novruzbekov

N.V. Sklifosovsky Research Institute for Emergency Medicine; N.N. Blokhin National Medical Research Center of Oncology

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2019 in Transplantologiya. The Russian Journal of Transplantation
Verified
Journal Article
Open access
PDF file
VGV. A. Gulyaev
V. A. Gulyaev
MKM. Sh. Khubutiya
M. Sh. Khubutiya
MNM. S. Novruzbekov
M. S. Novruzbekov
AMA. S. Mironov
A. S. Mironov
OOO. D. Olisov
O. D. Olisov
BYB. I. Yaremin
B. I. Yaremin
The paper reviews the milestones and prerequisites in the history of the emergence and development of xenotransplantation. The currently existing barriers (immunological, infectious, genetic, ethical, and regulatory) to the development of this organ and tissue transplantation type have been studied. Available data on theoretical research and experimental studies have been reviewed. The prospects for performing xenotransplantation in various combination of species have been assessed. The forms and variants of the xenograft rejection reaction have been described. Genetic engineering approaches to overcoming xenoimmunological incompatibility are described. An assessment is made of ways to overcome existing barriers and prospects for the further development of xenotransplantation as a scientific section of transplantology.

1 January 2017 in Transplantologiya. The Russian Journal of Transplantation
Verified
Journal Article
Open access
PDF file
MNM. S. Novruzbekov
M. S. Novruzbekov
OOO. D. Olisov
O. D. Olisov
Сосудистые осложнения после ортотопической трансплантации печени

24 May 2022 in Russian Journal of Gastroenterology, Hepatology, Coloproctology
Verified
Journal Article
Open access
PDF file
YAYu. V. Averyanova
Yu. V. Averyanova
EBE. M. Batyrshin
E. M. Batyrshin
ADA. E. Demko
A. E. Demko
GIG. E. Ivanova
G. E. Ivanova
VIVladimir Ivashkin
Vladimir Ivashkin
ЮАЮ. В. Аверьянова
Ю. В. Аверьянова
Aim. Current clinical recommendations address the epidemiology, causes, clinical manifestations and pathogenesis of possible immediate and long-term complications, as well as the problematic issues related to treatment and rehabilitation of adult short bowel syndrome patients.Key points. Short bowel syndrome (SBS) is a symptom complex of impaired digestion caused by the reduction of small intestine absorptive surface and manifested by intestinal failure (IF) of various severity (maldigestion and malabsorption) developing into malnutrition and systemic somatogenic disorders. The vital strategic aspects of its treatment are the personalisation of liquid, macro- and micronutrients consumption as well as avoidance of intestinal failure- and parenteral nutrition-associated complications. Various nutritional support regimes and the indications for infusion therapy and maintenance parenteral nutrition are considered in this patient category, also in outpatient settings. To mitigate the dependence on intravenous fluid- and nutrient administration and attain enteral autonomy in SBS-IF patients, the use of recombinant glucagon-like peptide-2 (GLP-2) is justified as exerting a pronounced trophic effect on the epithelial regenerative potential as well as structural and functional adaptation of intestinal mucosa. The SBS-IF patients prescribed with home parenteral nutrition and/or their caregivers should be trained in a special programme that covers the catheter care, preparation of infusion solutions and nutrient mixture container, infusion pump operation as well as the prevention, recognition and management of complications. The main referral indications for small bowel transplantation (SBT) are: fast-progressing cholestatic liver disease-complicated irreversible intestinal failure; thrombosis of two or more central venous conduits used for parenteral nutrition; recurrent catheter-associated bloodstream infection.Conclusion. Current recommendations on diagnosis and treatment as well as the developed criteria of medical aid quality assessment are applicable at different levels of healthcare.

27 June 2018 in Transplantologiya. The Russian Journal of Transplantation
Verified
Journal Article
Open access
MKM. Sh. Khubutiya
M. Sh. Khubutiya
LZL. N. Zimina
L. N. Zimina
IGI. E. Galankina
I. E. Galankina
VGV. A. Gulyaev
V. A. Gulyaev
MNM. S. Novruzbekov
M. S. Novruzbekov
KMK. M. Magomedov
K. M. Magomedov
Дефицит донорских органов способствовал активному использованию доноров с расширенными критериями оценки. Основным методом оценки было гистологическое исследование биоптатов трансплантата печени до (0-биопсия) и после реперфузии (1-биопсия). Тяжелые ишемические и реперфузионные повреждения среди реципиентов, получивших трансплантат печени, составили 20,4% и 16,6% соответственно. В исследовании показано отсутствие влияния мелко- и среднекапельного, а также крупнокапельного стеатоза (менее 50%) на реперфузионные повреждения трансплантата.

26 December 2024 in Journal of oncology: diagnostic radiology and radiotherapy
Verified
Journal Article
Open access
PDF file
IMI. V. Molostova
I. V. Molostova
BMB. M. Medvedeva
B. M. Medvedeva
EKE. V. Kondratyev
E. V. Kondratyev
AUA. A. Ustalov
A. A. Ustalov
MNM. S. Novruzbekov
M. S. Novruzbekov
VTV. M. Tarnoposky
V. M. Tarnoposky
Purpose: To evaluate machine-learning radiomics based models on enhanced MR images in diagnostics of early HCC.Material and methods: Data from 72 patients with 93 masses who underwent Gadoxetic acid-enhanced MRI scans was retrospectively analyzed.Results: Binary classification models were produced for the differential diagnosis of regenerative and dysplastic nodes, early HCC and HCC nodes with an atypical enhancement with high discriminatory capabilities; the area under the ROC-curve ranged from 0.89 to 0.95 in various models.Conclusion: The performed radiomic models can be used as an effective method for differential diagnostics of HCC with typical and atypical enhancement, dysplastic and regenerative nodes.

19 December 2022 in Transplantologiya. The Russian Journal of Transplantation
Verified
Journal Article
Open access
PDF file
VSV. E. Syutkin
V. E. Syutkin
ASA. A. Salienko
A. A. Salienko
OOO. D. Olisov
O. D. Olisov
MNM. S. Novruzbekov
M. S. Novruzbekov
Background. The recurrence of autoimmune liver diseases can lead to reduced survival of recipients and grafts.Aim. To study the incidence and impact of the recurrence of autoimmune liver diseases on graft survival; the effect of maintenance immunosuppression on the recurrence of autoimmune diseases in liver transplant recipientsMaterial and methods. Transplantation outcomes in 111 recipients (21 recipients operated on for autoimmune hepatitis, 50 recipients operated on for primary biliary cirrhosis, and 40 recipients operated on for primary sclerosing cholangitis) were analyzed retrospectively.Results. The recurrence of autoimmune hepatitis is observed in 5%, the recurrence of primary biliary cirrhosis is in 10%, and the recurrence of primary sclerosing cholangitis is in 17% of cases. Among patients with recurrence of autoimmune diseases, men accounted for 54%, while for only 31% in the subgroup of patients without relapse (p=0.004). The followup for recipients with relapse (64.5 (42.8;82.0) months) was comparable to the follow-up for recipients without relapse (46.5 (17.9;103.5) months, p=0.54). A ten-year graft survival was significantly higher in the group of recipients with recurrent autoimmune diseases compared with recipients without autoimmune diseases recurrence (p<0.0001).Conclusions. The recurrence of autoimmune diseases leads to a decrease in graft survival. The effect of immunosuppression components on the risk of recurrence of autoimmune diseases in the graft has not been established.